Rat model for dual opportunistic pathogen prophylaxis: Cryptosporidium parvum and Pneumocystis carinii

Laboratory Animal Science

Volumn 49, Issue 3, 1999, Pages 331-334

  Oz, Helieh S ^a   Hughes, Walter T ^a   Rehg, Jerold E ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ATOVAQUONE; AZITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; LASALOCID; MADURAMICIN; PAROMOMYCIN; PENTAMIDINE; PRIMAQUINE; RECOMBINANT GAMMA INTERFERON; TRIMETREXATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; DRUG EFFICACY; EXPERIMENTAL INFECTION; FEMALE; HISTOPATHOLOGY; IMMUNE DEFICIENCY; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; OPPORTUNISTIC INFECTION; ORAL DRUG ADMINISTRATION; PNEUMOCYSTIS CARINII; PNEUMOCYSTOSIS; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; SUPERINFECTION;

ANIMALS; CARBAMATES; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; DEXAMETHASONE; DISEASE MODELS, ANIMAL; FEMALE; ILEUM; IMMUNOCOMPROMISED HOST; LUNG; NAPHTHOQUINONES; PNEUMOCYSTIS; PNEUMONIA, PNEUMOCYSTIS; PRODRUGS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0033015382     PISSN: 00236764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Hughes, W. T. 1987. Pneumocystis carinii pneumonitis, vol. 1, p. 1-131. CRC Press, Boca Raton, Fla.
2. Soave, R., and W. D. Johnson. 1988. Cryptosporidium and Isospora belli infections. J. Infect. Dis. 157:225-229.
3. Kovacs, J. A., J. W. Hiemenz, A. M. Macher, et al. 1984. Pneumocystis carinii: a comparison between patients with acquired immunodeficiency syndrome and patients with other immunodeficiencies. Ann. Intern. Med. 100:663-671.
4. Scaglia, M., C. Atzori, G. Marchetti, et al. 1994. Effectiveness of aminosidine (Paromomycin) sulfate in chronic Cryptosporidium diarrhea in AIDS patients: an open, uncontrolled, prospective clinical trial. J. Infect. Dis. 170: 1349-1350.
5. Angarano, G., P. Maggi, M. A, Bari, et al. 1997. Giardiasis in HIV: a possible role in patients with severe immune deficiency. Eur. Epidemiol. 13:485-487.
6. Yinnon, A. M., and R. F. Betts. 1994. Pneumocystis carinii pneumonia associated with concurrent cryptococcosis or toxoplasmosis in patients with AIDS. Clin. Infect. Dis. 18: 113-114.
7. Hughes, W. T., P. C. McNabb, T. D. Markres, et al. 1974. Efficacy of trimethoprim and sulfamethoxazole in the prevention and treatment of Pneumocystis carinii pneumonitis. Antimicrob. Agents Chemother. 5:289-293.
8. Hughes, W. T., V. L. Gray, W. E. Gutteridge, et al. 1990. Efficacy of a hydroxynaphthoquinone, 566C80, in experimental Pneumocystis carinii pneumonitis. Antimicrob. Agents Chemother. 34:225-228.
9. Queener, S. F., M. S. Bartlett, J. D. Richardson, et al. 1988. Activity of clindamycin with primaquine against Pneumocystis carinii in vitro and in vivo. Antimicrob. Agents Chemother. 32:807-813.
10. Allegro, C. J., J. A. Kovacs, J. C. Drake, et al. 1987. Activity of antifolates against Pneumocystis carinii dihydrofolate reductase and identification of a potent new agent. J. Exp. Med. 165:926-931.
11. Waldman, R. H., D. E. Pearce, and R. A. Martin. 1973. Pentamidine isethionate levels in lungs, livers and kidneys of rats after aerosol or intramuscular administration. Am. Rev. Respir. Dis. 108:1004-1006.
12. Oz, H. S., W. T. Hughes, and J. E. Rehg. 1997. Efficacy of lasalocid against Pneumocystis carinii pneumonitis. Antimicrob. Agents Chemother. 41:191-192.
13. Rehg, J. E. 1993. Anticryptosporidial activity of lasalocid and other ionophorous antibiotics in immunosuppressed rats. J. Infect. Dis. 168:1566-1569.
14. Rehg, J. E. 1996. Effect of diethyldithiocarbamate on Cryptosporidium parvum infection in immunosuppressed rats. J. Parasitol. 82:158-162.
15. Rehg, J. E. 1994. A comparison of anticryptosporidial activity of paromomycin with that of other aminoglycosides and azithromycin in immunosuppressed rats. J. Infect. Dis. 170:934-938.
16. Oz, H. S., and W. T. Hughes. 1996. Effect of sex and dexamethasone dose on the experimental host for Pneumocystis carinii. Lab. Anim. Sci. 46:109-110.
17. Rehg, J. E., M. L. Hancock, and D. B. Woodmansee. 1988. Characterization of a dexamethasone-treated rat model of cryptosporidial infection. J. Infect. Dis. 158:1406-1407.
18. Hughes, W. T., and B. L. Smith. 1984. Efficacy of diaminodiphenylsulfone and other drugs in murine Pneumocystis carinii pneumonitis. Antimicrob. Agents Chemother. 26:436-440.
19. Pavlasek, I. 1984. First record of developmental stages of Cryptosporidium sp. in various organs of experimentally infected mice and spontaneously infected calves. Folia Parasitol. 31:191-192.
20. Brun-Pascaud, M., F. Chau, A. M. Simonpoli, et al. 1994. Experimental evaluation of combined prophylaxis against murine Pneumocystis carinii and toxoplasmosis. J. Infect. Dis. 170:653-658.
21. Shear, H. L., G. Valladares, and M. A. Narachi. 1990. Enhanced treatment of Pneumocystis carinii pneumonia in rats with interferon-γ and reduced doses of trimethoprim/ sulfamethoxazole. J. Acquir. Immune Defic. Syndr. 3:943-948.